Physician attitudes on buprenorphine induction in the emergency department: results from a multistate survey.


Journal

Clinical toxicology (Philadelphia, Pa.)
ISSN: 1556-9519
Titre abrégé: Clin Toxicol (Phila)
Pays: England
ID NLM: 101241654

Informations de publication

Date de publication:
Apr 2021
Historique:
pubmed: 2 9 2020
medline: 7 9 2021
entrez: 2 9 2020
Statut: ppublish

Résumé

Emergency Departments (ED) are rapidly becoming an important location for initiation of buprenorphine (EDBUP) for the treatment of opioid use disorder (OUD). Previous investigations of emergency medicine physicians' perceived barriers and attitudes toward EDBUP exclusively sampled from urban, academic-affiliated physicians. We administered a multistate survey to an institutionally and geographically diverse collection of emergency medicine physicians to better understand the professional opinions of EDBUP implementation across a variety of practice settings. This cross-sectional survey study used an online survey instrument to convenience sample emergency medicine physicians. In order to sample from various practice environments, participants were identified from (1) statewide ACEP chapters and (2) Facebook groups exclusive to emergency medicine physicians. The survey explored physicians' attitudes of EDBUP adoption and the perceived barriers to doing so. 162 emergency medicine physicians completed the survey. 76% of respondents agreed that emergency medicine physicians should offer EDBUP in the treatment of OUD. When stratified by practice setting and X-waiver status, 96% of X-waivered physicians, 73% of academic physicians, 49% of non-academic physicians, and 34% of non-X-waivered physicians felt comfortable initiating EDBUP. Lack of access to outpatient MOUD referral was the most frequently cited barrier to EDBUP across all practice settings. An institutionally and geographically diverse group of emergency medicine physicians endorsed substantial support for EDBUP. Emergency medicine physicians practicing in different clinical environments endorsed similar barriers to EDBUP implementation.

Identifiants

pubmed: 32870039
doi: 10.1080/15563650.2020.1805461
doi:

Substances chimiques

Analgesics, Opioid 0
Narcotic Antagonists 0
Buprenorphine 40D3SCR4GZ

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

279-285

Auteurs

Matthew Zuckerman (M)

Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, CO, USA.

Timothy Kelly (T)

Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, CO, USA.

Kennon Heard (K)

Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, CO, USA.

Amy Zosel (A)

Department of Emergency Medicine, Section of Medical Toxicology, Medical College of Wisconsin, Milwaukee, WI, USA.

Michael Marlin (M)

Department of Emergency Medicine, Medical Toxicology Services, University of Mississippi Medical Center, MI, USA.

Jason Hoppe (J)

Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, CO, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH